Journal of Anesthetics and Anesthesiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Journal of Anesthetics and Anesthesiology (2023) Volume 5, Issue 4

Clotting Control: Anaesthesia Considerations for Cardiac Surgery Bleeding.

Marina Lopez*

Erasmus University Rotterdam

*Corresponding Author:
Marina Lopez
Department of Cardiology,
Hospital Universitari de La Ribera,
Valencia, Spain
E-mail: Marinal444@hotmail.com

Received:29-Jul-2023, Manuscript No. AAAA-23-109599; Editor assigned:03-Aug -2023, PreQC No. AAAA-23-109599 (PQ); Reviewed:17-Aug-2023, QC No. AAAA-23-109599; Revised:22-Aug-2023, Manuscript No. AAAA-23-109599 (R); Published:30-Aug-2023, DOI:10.35841/ aaaa-5.4.159

Citation: Lopez M. Clotting Control: Anaesthesia Considerations for Cardiac Surgery Bleeding. J Anesthetic Anesthesiol. 2023;5(4):159

Visit for more related articles at Journal of Anesthetics and Anesthesiology

Introduction

The world of cardiac surgery is a realm where precision meets complexity, where the rhythm of the heart and the flow of blood intertwine in a delicate dance of life. Among the myriad challenges that cardiac surgeons and their teams face, the control of bleeding stands as a formidable adversary. In this intricate landscape, anesthesia practitioners play a pivotal role in orchestrating clotting control, ensuring patient safety and optimal surgical outcomes[1].

Cardiac surgeries are intricate and demanding procedures that involve delicate maneuvers within a highly sensitive environment. The heart, a vital organ responsible for pumping oxygenated blood throughout the body, demands meticulous care during surgery. However, this life-sustaining organ can also pose challenges due to its complex anatomy and dynamic circulation[2].

Bleeding, though essential for life, can become a significant concern during cardiac surgery. Uncontrolled bleeding can compromise the surgeon's field of vision, prolong the surgery, lead to complications, and even endanger the patient's life. Here is where the skillful management of anesthesia steps into the spotlight[3].

The Anesthesia Practitioner's Role in Clotting Control:

  • Anesthesia practitioners are the conductors of the intricate symphony that is a cardiac surgery procedure. They are tasked with maintaining the patient's vital signs, administering medications, ensuring pain management, and crucially, managing clotting control.
  • Anesthesia practitioners carefully administer medications that influence clotting factors, aiming to strike a balance between preventing excessive bleeding and avoiding clot formation. These medications may include anticoagulants to prevent clots and hemostatic agents to promote clotting.
  • Monitoring devices play a crucial role in assessing the patient's clotting status. Coagulation monitoring tools, such as thromboelastography (TEG) or rotational thromboelastometry (ROTEM), provide real-time data on clot formation and breakdown, helping anesthesia teams make timely interventions.
  • Effective clotting control requires a collaborative effort between anesthesia teams, surgeons, perfusionists, and nursing staff. Communication is paramount to adjust medication dosages, transfusion requirements, and surgical strategies based on the patient's evolving condition.
  • Successful clotting control during cardiac surgery hinges on a multidimensional approach.
  • Each patient's clotting profile is unique. Anesthesia practitioners tailor their approach based on preoperative assessments, patient history, and ongoing monitoring to ensure a personalized strategy. • Anesthesia teams administer medications with precision, adjusting dosages based on real-time coagulation data to maintain the delicate equilibrium between bleeding and clotting.
  • Monitoring devices enable prompt interventions. Anesthesia practitioners can adjust medication dosages or recommend transfusions if necessary, minimizing the risk of excessive bleeding. 
  • Anesthesia teams may employ hemostatic agents like tranexamic acid to enhance clot stability, reducing bleeding risks during surgery [4].

The complexities of cardiac surgery extend beyond the operating room. After the procedure, anesthesia practitioners continue to monitor the patient's clotting profile in the intensive care unit, ensuring a smooth transition to postoperative care. In the grand tapestry of cardiac surgery, clotting control is a thread interwoven with expertise, innovation, and collaboration. Anesthesia practitioners, armed with scientific knowledge and clinical acumen, play an indispensable role in managing bleeding challenges. Through their efforts, the delicate balance between preventing excessive bleeding and ensuring proper hemostasis is achieved, contributing to the success of cardiac surgical procedures and the well-being of the patients they serve[5].

Conclusion

In the grand tapestry of cardiac surgery, clotting control is a thread interwoven with expertise, innovation, and collaboration. Anesthesia practitioners, armed with scientific knowledge and clinical acumen, play an indispensable role in managing bleeding challenges. Through their efforts, the delicate balance between preventing excessive bleeding and ensuring proper hemostasis is achieved, contributing to the success of cardiac surgical procedures and the well-being of the patients they serve.

References

  1. Karkouti K, Callum J, Wijeysundera DN, et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circ. 2016;134(16):1152-62.

    2. Indexed at, Google Scholar,Cross Ref

  2. Diprose P, Herbertson MJ, O'shaughnessy D, et al. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth. 2005;95(5):596-602.

    3. Indexed at, Google Scholar,Cross Ref

  3. Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9(2):168-73..

    4. Indexed at, Google Scholar, Cross Ref

  4. McGill N, O'Shaughnessy D, Pickering R, et al. Mechanical methods of reducing blood transfusion in cardiac surgery: Randomised controlled trial. Br Med J. 2002;324(7349):1299.

    5. Indexed at, Google Scholar, Cross Ref

  5. Boer C, Meesters MI, Veerhoek D, et al. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth. 2018;120(5):914-27.

    6. Indexed at, Google Scholar, Cross Ref

Get the App